Target Power for BE Studies [Power / Sample Size]

posted by Sereng  – USA, 2022-05-12 19:45 (270 d 10:48 ago) – Posting: # 22978
Views: 860

Dear colleagues, is there a "convention" for power assumptions in a BE study sample size calculation. I realize this will depend on "risk tolerance" but what do YOU use, e.g., 80%, 90% etc.
Regards

Biostatistically Challenged CEO

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
19 visitors (0 registered, 19 guests [including 11 identified bots]).
Forum time: 05:33 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5